Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
human cord blood-derived mononuclear cells (HCB-MNCs)
The First People's Hospital of Lianyungang
Refractory Diabetic Foot
1 trial -
insulin aspart
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Type 2 Diabetes Mellitus
1 trial -
intranasal oxytocin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy
7 trials -
intranasal oxytocin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Learning Disabilities
1 trial -
iodine-containg spareribs soup
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Iodine Bioavailability
1 trial -
irinotecan hydrochloride liposome injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Biliary Tract Carcinoma
1 trial -
laronidase
BioMarin Pharmaceutical Australia Pty Ltd
Cognitive Decline
1 trial -
lidocaine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colorectal Cancer
2 trials -
megestrol
Ultragenyx UK Limited
Acquired Immunodeficiency Syndrome
1 trial -
metoclopramide or mosapride
The First People's Hospital of Lianyungang
Severe Stroke
1 trial -
mitomycin C
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Obstructive Airway Disease
1 trial -
modified Ma Xing Shi Gan Decoction
Universal Integrated
Chronic Obstructive Pulmonary Disease
1 trial -
multi-intervention program and protein foods supplementation
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sarcopenia
1 trial -
n-3 Polyunsaturated fatty acid
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cardiovascular Diseases
1 trial -
nutrition treat
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Crohn's Disease
1 trial -
omega-3 polyunsaturated fatty acids
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Type 2 Diabetes Mellitus
1 trial -
only antiemetic (Ramosetron, Tropisetron and dexamethasone)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chemotherapy-induced Nausea and Vomiting
1 trial -
oxygen
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sepsis
1 trial -
oxytocin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Interoception
1 trial -
oxytocin treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy
1 trial -
phosphatidylcholine
Ultragenyx UK Limited
Methionine Adenosyltransferase Deficiency
1 trial -
phytic acid
United Therapeutics Europe Ltd
Iron-deficiency
1 trial -
placebo (compared to vasoconstrictor)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy Adult Male
1 trial -
postbiotics
Xiyuan Hospital of China Academy of Chinese Medical Sciences
ADHD - Attention Deficit Disorder With Hyperactivity
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources